Inogen, Inc.
PosiFunda Ratios Only on PositoAI
PositoAI's own ratios from Inogen, Inc.'s yearly results (2022–2025), compared with Healthcare companies in United States. Tap ? on any ratio for what it means.
Cash quality
Profit Cash Ratio
—Loss-making or profit too small
Over the last 3 years profit was a loss or under 2% of sales, so cash per 100 of profit is not meaningful.
Self-Funding Ratio
-0.2×Over the last 3 years operating cash was negative while the company kept spending on investment (capex).
Higher than 63% of Healthcare companies in United States.
Cash Locked Ratio
$13For every $100 of sales, $13 is tied up in day-to-day operations (money owed by customers + stock − money owed to suppliers), against $21 tied up three years earlier.
Less money tied up than 74% of Healthcare companies in United States.
Growth quality
Steadiness Ratio
2/3 · 2/3Sales grew in 2 of the last 3 years; profit grew in 2 of 3.
Steadier than 69% of Healthcare companies in United States.
Growth Efficiency Ratio
—Sales fell 8%
Sales fell 8% in 3 years, so extra profit per extra sales cannot be measured.
Asset Productivity Ratio
-8% / -26%In 3 years sales changed by -8% while total assets changed by -26%. Sales grew faster than assets.
Balance-sheet strength
Debt Due Cover Ratio
-3.5×Operating cash was negative last year, while some debt falls due within a year.
Higher than 61% of Healthcare companies in United States.
Cash Cushion Ratio
+55%Cash, after subtracting all debt, equals 55% of its market value (net cash).
Higher than 78% of Healthcare companies in United States.
Tangible Assets Ratio
86%Of every $100 the company owns, $86 is in tangible assets such as plants, cash, stock and receivables; the rest is goodwill and other intangibles.
More tangible than 57% of Healthcare companies in United States.
Tangible Net Worth Ratio
78%Of every $100 of net worth, $78 is tangible; the rest is goodwill and other intangibles, often from buying other companies.
More tangible than 60% of Healthcare companies in United States.
Shareholders
Standard fundamentals
P/E, P/B, ROE, debt, growth and more (12)
Inogen, Inc. made a loss over the last year. Inogen, Inc. owes $0.39 for every $1 it owns. Inogen, Inc. made a loss in each of the last two years.
Compared with Healthcare companies in United States · latest annual results Dec 2025.
P/E ratio
LossInogen, Inc. made a loss over the last year, so its P/E ratio is not meaningful.
P/B ratio
1.07The share price is 1.07 times Inogen, Inc.'s book value per share, lower than 77% of Healthcare companies in United States.
Market cap
$187 MThe total market value of all of Inogen, Inc.'s shares at today's price (share price × number of shares), smaller than 58% of Healthcare companies in United States. PosiCap size class: Mini Cap.
Net worth (book value)
$175 MWhat Inogen, Inc. would have left on paper if it sold everything it owns and paid everything it owes, from its latest balance sheet (30 Jun 2026).
Book value per share
$6.59Net worth divided by the number of shares. The share price of $7.04 is 1.1 times this, which is the P/B above.
Return on equity (ROE)
-13.1%Inogen, Inc. lost 13.1% of its shareholders' money over the last year, higher than 69% of Healthcare companies in United States.
Owes vs Owns
0.39×Inogen, Inc. owes $0.39 for every $1 it owns (low), lower than 52% of Healthcare companies in United States.
Dividend yield
NoneInogen, Inc. does not currently pay a dividend.
Revenue growth
+4%Revenue rose 4% in the year to Dec 2025, and shrank 3% a year on average over 3 years.
Profit growth
LossInogen, Inc. made a loss in each of the last two years.
Profit margin
-6.5%Inogen, Inc. lost $7 for every $100 of revenue.
Cash vs debt
Net cashInogen, Inc. held $102 M more cash than debt (net cash) at Dec 2025.
Questions
How is P/B calculated on PositoAI?
P/B is market cap divided by net worth from the latest balance sheet. For Inogen, Inc.: $187 M ÷ $175 M (30 Jun 2026) = 1.1.
What is Inogen, Inc.'s return on equity?
Inogen, Inc. lost 13.1% of its shareholders' money over the last year, higher than 69% of Healthcare companies in United States.
How much does Inogen, Inc. owe compared with what it owns?
Inogen, Inc. owes $0.39 for every $1 it owns (low), lower than 52% of Healthcare companies in United States.
Does Inogen, Inc. pay a dividend?
No. Inogen, Inc. does not currently pay a dividend.
Is Inogen, Inc.'s revenue growing?
Revenue rose 4% in the year to Dec 2025, and shrank 3% a year on average over 3 years.
Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.